Lyase and DNA Encoding the Lyase, Vectors Containing DNA, and Methods for Asymmetric Synthesis of (S)-Phenylacetylcarbinol

Publication: DE102014013644A1
Published: 2016-03-17
Family Size: 12
Granted: Yes (4/12)

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes a genetically engineered lyase enzyme and the corresponding DNA which codes for it, as well as vectors containing this DNA. The main innovation is a modified form of the enzyme ApPDC-E469G (from Acetobacter pasteurianus), where the amino acid tryptophan at position 543 is replaced with a less bulky amino acid. This engineered enzyme is used in a process for the highly enantioselective (asymmetric) synthesis of (S)-phenylacetylcarbinol (S-PAC) from inexpensive, non-chiral starting materials such as benzaldehyde and pyruvate or acetaldehyde, achieving very high enantiomeric excess (up to 97%).

Use CasesContent extracted from patent full text and abstract with AI.

  • Production of (S)-phenylacetylcarbinol for use as a chiral building block in pharmaceutical manufacturing, especially for drugs like ephedrine and pseudoephedrine.
  • Synthesis of fine chemicals where high-purity (S)-phenylacetylcarbinol is required.
  • Industrial biocatalytic processes replacing less selective chemical methods for making chiral intermediate compounds.
  • Biotechnology applications involving engineered microorganisms for efficient chiral compound synthesis.

BenefitsContent extracted from patent full text and abstract with AI.

  • Achieves very high enantiomeric excess of (S)-phenylacetylcarbinol (up to 97% ee), reducing or eliminating the need for costly purification/separation of enantiomers.
  • Utilizes inexpensive, non-chiral starting materials, making the process more cost-effective and scalable.
  • The engineered enzyme produces little to no by-products or regioisomers, simplifying downstream processing.
  • Can be used with isolated enzyme, cell extracts, or whole cells, offering flexibility in bioprocess approaches.
  • Enables more sustainable and environmentally friendly synthesis routes compared to traditional chemical methods.

Technical Classifications (CPCs)

Main Classifications

Chemistry & Materials Science

Sub Classifications

Biochemistry, Beer & Spirits

CPC Codes

C12N9/88C12P7/26C12Y401/01001

Inventors & Applicants

Applicants

Forschungszentrum Juelich Gmbh

Patent Abstract

The invention relates to a lyase and a lyase-encoding DNA, to vectors containing the DNA and to a method for the asymmetric synthesis of (S)-phenylacetylcarbinol. According to the invention, a lyase is provided, in which tryptophan is replaced with an amino acid at position 543 in protein ApPDC-E469G, said protein being modified with respect to the wild type of Aceobacter pasteurianus, or in which it is less space-filling than tryptophan. According to the invention, deoxyribonucleic acids are furthermore provided, which encode the lyase. (S)-phenylacetylcarbinol can be produced with the lyase according to the invention from the educts benzaldehyde and pyruvate or acetaldehyde with an enantiomeric excess of at least 94 %.

Key Information

Publication No.

DE102014013644A1

Family ID

54151041

Publication Date

2016-03-17

Application No.

DE102014013644A

Application Date

2014-09-16

Priority Date

2014-09-16

Granted

Yes (4/12)

Possible Cooperation

For further information please contact the transfer office.